Sorrento Therapeutics Inc 's ability to collect accounts receivable sequentially worsen to 2.38, indicating more challenging environment then in the first quarter 2023, but still, it is a far cry from any concerns. Sorrento Therapeutics Inc 's Accounts Receivable average collection period in the Jun 30 2023 quarter, has increased to 153 days, from 150 days, in the Mar 31 2023 quarter.

If we take a look into Healthcare sector 520 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2023 from 0 to 3523.

What is Receivable Turnover Ratio?
What is Sorrento Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

SRNEQ Receivables Turnover Ratio	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter
Y / Y Receivable Change	32.41 %	7.5 %	30.75 %	47.02 %	10.15 %
Y / Y Revenue Change	31.1 %	-11.61 %	19.26 %	44.25 %	-15.17 %
Receivable Turnover Ratio (TTM)	2.38	2.43	2.56	2.61	2.6
SRNEQ's Total Ranking	# 3523	# 0	# 0	# 0	# 0
Accounts Receivable average collection period days	153	150	142	140	140
Seq. Receivable Change	23.38 %	8.4 %	1.15 %	-2.12 %	0.17 %
Seq. Revenue Change	-7.54 %	4.21 %	-10.38 %	51.82 %	-37.66 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 44
Healthcare Sector	# 521
Overall Market	# 3523

Receivable Turnover Ratio Statistics
High	Average	Low
0.38	0.08	0.01
(Dec 31 2017)		(Dec 31 2013)

SRNEQ Company Profile • Back to SRNEQ Efficiency Comparisons • Compare SRNEQ Receivables Turnover Ratio to its Competitors

Financial Statements
Sorrento Therapeutics Inc 's Accounts Receivable	$ 33 Millions	Visit SRNEQ's Balance sheet
Sorrento Therapeutics Inc 's Sales TTM	$ 64 Millions	Visit SRNEQ's Income Statement
Sources of SRNEQ's Revenues		Visit SRNEQ's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
SRNEQ's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
SRNEQ's Growth Rates	SRNEQ's Roa	SRNEQ's Inventory Turnover Ratio	SRNEQ's Dividend Comparisons
SRNEQ's Profitability Ratios	SRNEQ's Roi	SRNEQ's Asset Turnover Ratio	SRNEQ's Dividend Growth
SRNEQ's Valuation Ratios	SRNEQ's Roe	SRNEQ's Financial Strength Ratios	SRNEQ's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2023, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2023	Receivable at quarter ending Jun 30 2023
Emergent Biosolutions Inc	5.39	$ 1,073.200 Millions	$ 199.125 Millions
Charles River Laboratories International inc	5.37	$ 4,178.310 Millions	$ 778.030 Millions
Twist Bioscience Corporation	5.37	$ 235.470 Millions	$ 43.875 Millions
Bausch and Lomb Corp	5.36	$ 3,904.000 Millions	$ 728.500 Millions
Precision Optics Corporation Inc	5.35	$ 21.044 Millions	$ 3.936 Millions
Zimmer Biomet Holdings Inc	5.32	$ 7,195.500 Millions	$ 1,352.050 Millions
Teva Pharmaceutical Industries Limited	5.30	$ 15,017.000 Millions	$ 2,835.000 Millions
Stereotaxis Inc	5.29	$ 28.693 Millions	$ 5.422 Millions
Volitionrx Limited	5.28	$ 0.519 Millions	$ 0.098 Millions
Biolife Solutions Inc	5.25	$ 162.217 Millions	$ 30.894 Millions
Eiger Biopharmaceuticals Inc	5.24	$ 15.481 Millions	$ 2.953 Millions
Cutera Inc	5.24	$ 244.876 Millions	$ 46.716 Millions
Zimvie Inc	5.23	$ 920.488 Millions	$ 176.068 Millions
Fulgent Genetics Inc	5.22	$ 307.099 Millions	$ 58.817 Millions
Sight Sciences Inc	5.22	$ 81.135 Millions	$ 15.550 Millions
Caribou Biosciences Inc	5.19	$ 14.252 Millions	$ 2.744 Millions
Sonoma Pharmaceuticals Inc	5.19	$ 12.716 Millions	$ 2.449 Millions
Caremax Inc	5.18	$ 719.356 Millions	$ 138.901 Millions
Psychemedics Corporation	5.17	$ 23.137 Millions	$ 4.478 Millions
Mersana Therapeutics inc	5.16	$ 38.717 Millions	$ 7.500 Millions
Tenon Medical Inc	5.15	$ 1.661 Millions	$ 0.322 Millions
Tactile Systems Technology Inc	5.15	$ 266.307 Millions	$ 51.681 Millions
Guardion Health Sciences Inc	5.15	$ 9.399 Millions	$ 1.825 Millions
Iradimed Corporation	5.15	$ 59.876 Millions	$ 11.635 Millions
Therapeutic Solutions International Inc	5.14	$ 0.133 Millions	$ 0.026 Millions
Avanos Medical Inc	5.12	$ 780.100 Millions	$ 152.275 Millions
Alkermes Plc	5.09	$ 1,462.023 Millions	$ 287.199 Millions
Inhibikase Therapeutics Inc	5.09	$ 0.252 Millions	$ 0.049 Millions
Labcorp Holdings Inc	5.08	$ 14,091.900 Millions	$ 2,773.150 Millions
Cardiff Oncology Inc	5.07	$ 2.863 Millions	$ 0.565 Millions

Date modified: 2026-08-29T17:19:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.